Cyclooxygenase-2 expression and prostanoid biogenesis reflect clinical phenotype in human colorectal fibroblast strains

Yingting Zhu, Ping Hua, Michael P Lance

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Up-regulated cyclooxygenase (COX)-2 expression and prostaglandin E2 (PGE2) synthesis contribute causally to the early stages of colorectal neoplasia and carcinogenesis, yet COX-2 expression is barely detectable in normal and premalignant colorectal epithelium. Rather, COX-2 expression in nonmalignant colonic tissue is probably confined to subepithelial cells, such as fibroblasts. We established a panel of 33 primary subepithelial fibroblast strains from human colonoscopic biopsies of normal colon (group I), normal segments of colons that harbored synchronous advanced neoplasms in remote segments (group II), advanced neoplasms (group III), and segments of active ulcerative colitis (group IV). In group I strains, mean basal and peak PGE2 levels after 24 h of interleukin (IL)-1β stimulation were 5.4 ± 1.1 and 32.8 ± 4.9 ng/mg protein, respectively. Mean IL-1β-stimulated peak levels in groups II, III, and IV strains were, respectively, 6-, 9-, and 7-fold greater than that in group I (P < 0.001 for each comparison), and inductions of COX-2 mRNA and protein were consistent with these findings. IL-1β-mediated stimulation of PGE2 was fully blocked in the presence of a nonselective COX inhibitor (indomethacin) or a selective COX-2 inhibitor (NS-398). IL-1β treatment elicited from group I (normal) and group III (cancer-associated) fibroblasts, respectively, ∼2- and 3-fold inductions of COX-2 transcriptional activity and ∼1.4- and 1.7-fold inductions of COX-2 promoter activity. This modestly greater COX-2 transcription rate could not alone account for the dramatically higher levels of COX-2 mRNA and protein and PGE2 in cancer-associated compared with normal fibroblasts. However, incubation of fibroblasts with PGE2 after IL-1β stimulation prolonged COX-2 mRNA half-life from ∼1 to 9 h. Our results strengthen the evidence that fibroblasts and other mesenchymal cells are the source of COX-2 expression in normal and premalignant colorectal tissue. Group II fibroblasts from normal segments of colons that harbored synchronous remote advanced neoplasms behaved like group III fibroblasts from advanced neoplasms and not group I fibroblasts from normal colons. We hypothesize that the effects of modestly greater COX-2 transcription in groups II-IV fibroblasts yield corresponding modest increases in PGE2 synthesis whose effects are progressively amplified through robust stabilization of COX-2 mRNA.

Original languageEnglish (US)
Pages (from-to)522-526
Number of pages5
JournalCancer Research
Volume63
Issue number2
StatePublished - Jan 15 2003

Fingerprint

Cyclooxygenase 2
Prostaglandins
Fibroblasts
Phenotype
Dinoprostone
Interleukin-1
Colon
Messenger RNA
Neoplasms
Multiple Primary Neoplasms
Proteins
Cyclooxygenase Inhibitors
Cyclooxygenase 2 Inhibitors
Ulcerative Colitis
Indomethacin
Half-Life
Carcinogenesis
Epithelium
Biopsy

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Cyclooxygenase-2 expression and prostanoid biogenesis reflect clinical phenotype in human colorectal fibroblast strains. / Zhu, Yingting; Hua, Ping; Lance, Michael P.

In: Cancer Research, Vol. 63, No. 2, 15.01.2003, p. 522-526.

Research output: Contribution to journalArticle

@article{3b007db13423415f9bc967433efea153,
title = "Cyclooxygenase-2 expression and prostanoid biogenesis reflect clinical phenotype in human colorectal fibroblast strains",
abstract = "Up-regulated cyclooxygenase (COX)-2 expression and prostaglandin E2 (PGE2) synthesis contribute causally to the early stages of colorectal neoplasia and carcinogenesis, yet COX-2 expression is barely detectable in normal and premalignant colorectal epithelium. Rather, COX-2 expression in nonmalignant colonic tissue is probably confined to subepithelial cells, such as fibroblasts. We established a panel of 33 primary subepithelial fibroblast strains from human colonoscopic biopsies of normal colon (group I), normal segments of colons that harbored synchronous advanced neoplasms in remote segments (group II), advanced neoplasms (group III), and segments of active ulcerative colitis (group IV). In group I strains, mean basal and peak PGE2 levels after 24 h of interleukin (IL)-1β stimulation were 5.4 ± 1.1 and 32.8 ± 4.9 ng/mg protein, respectively. Mean IL-1β-stimulated peak levels in groups II, III, and IV strains were, respectively, 6-, 9-, and 7-fold greater than that in group I (P < 0.001 for each comparison), and inductions of COX-2 mRNA and protein were consistent with these findings. IL-1β-mediated stimulation of PGE2 was fully blocked in the presence of a nonselective COX inhibitor (indomethacin) or a selective COX-2 inhibitor (NS-398). IL-1β treatment elicited from group I (normal) and group III (cancer-associated) fibroblasts, respectively, ∼2- and 3-fold inductions of COX-2 transcriptional activity and ∼1.4- and 1.7-fold inductions of COX-2 promoter activity. This modestly greater COX-2 transcription rate could not alone account for the dramatically higher levels of COX-2 mRNA and protein and PGE2 in cancer-associated compared with normal fibroblasts. However, incubation of fibroblasts with PGE2 after IL-1β stimulation prolonged COX-2 mRNA half-life from ∼1 to 9 h. Our results strengthen the evidence that fibroblasts and other mesenchymal cells are the source of COX-2 expression in normal and premalignant colorectal tissue. Group II fibroblasts from normal segments of colons that harbored synchronous remote advanced neoplasms behaved like group III fibroblasts from advanced neoplasms and not group I fibroblasts from normal colons. We hypothesize that the effects of modestly greater COX-2 transcription in groups II-IV fibroblasts yield corresponding modest increases in PGE2 synthesis whose effects are progressively amplified through robust stabilization of COX-2 mRNA.",
author = "Yingting Zhu and Ping Hua and Lance, {Michael P}",
year = "2003",
month = "1",
day = "15",
language = "English (US)",
volume = "63",
pages = "522--526",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "2",

}

TY - JOUR

T1 - Cyclooxygenase-2 expression and prostanoid biogenesis reflect clinical phenotype in human colorectal fibroblast strains

AU - Zhu, Yingting

AU - Hua, Ping

AU - Lance, Michael P

PY - 2003/1/15

Y1 - 2003/1/15

N2 - Up-regulated cyclooxygenase (COX)-2 expression and prostaglandin E2 (PGE2) synthesis contribute causally to the early stages of colorectal neoplasia and carcinogenesis, yet COX-2 expression is barely detectable in normal and premalignant colorectal epithelium. Rather, COX-2 expression in nonmalignant colonic tissue is probably confined to subepithelial cells, such as fibroblasts. We established a panel of 33 primary subepithelial fibroblast strains from human colonoscopic biopsies of normal colon (group I), normal segments of colons that harbored synchronous advanced neoplasms in remote segments (group II), advanced neoplasms (group III), and segments of active ulcerative colitis (group IV). In group I strains, mean basal and peak PGE2 levels after 24 h of interleukin (IL)-1β stimulation were 5.4 ± 1.1 and 32.8 ± 4.9 ng/mg protein, respectively. Mean IL-1β-stimulated peak levels in groups II, III, and IV strains were, respectively, 6-, 9-, and 7-fold greater than that in group I (P < 0.001 for each comparison), and inductions of COX-2 mRNA and protein were consistent with these findings. IL-1β-mediated stimulation of PGE2 was fully blocked in the presence of a nonselective COX inhibitor (indomethacin) or a selective COX-2 inhibitor (NS-398). IL-1β treatment elicited from group I (normal) and group III (cancer-associated) fibroblasts, respectively, ∼2- and 3-fold inductions of COX-2 transcriptional activity and ∼1.4- and 1.7-fold inductions of COX-2 promoter activity. This modestly greater COX-2 transcription rate could not alone account for the dramatically higher levels of COX-2 mRNA and protein and PGE2 in cancer-associated compared with normal fibroblasts. However, incubation of fibroblasts with PGE2 after IL-1β stimulation prolonged COX-2 mRNA half-life from ∼1 to 9 h. Our results strengthen the evidence that fibroblasts and other mesenchymal cells are the source of COX-2 expression in normal and premalignant colorectal tissue. Group II fibroblasts from normal segments of colons that harbored synchronous remote advanced neoplasms behaved like group III fibroblasts from advanced neoplasms and not group I fibroblasts from normal colons. We hypothesize that the effects of modestly greater COX-2 transcription in groups II-IV fibroblasts yield corresponding modest increases in PGE2 synthesis whose effects are progressively amplified through robust stabilization of COX-2 mRNA.

AB - Up-regulated cyclooxygenase (COX)-2 expression and prostaglandin E2 (PGE2) synthesis contribute causally to the early stages of colorectal neoplasia and carcinogenesis, yet COX-2 expression is barely detectable in normal and premalignant colorectal epithelium. Rather, COX-2 expression in nonmalignant colonic tissue is probably confined to subepithelial cells, such as fibroblasts. We established a panel of 33 primary subepithelial fibroblast strains from human colonoscopic biopsies of normal colon (group I), normal segments of colons that harbored synchronous advanced neoplasms in remote segments (group II), advanced neoplasms (group III), and segments of active ulcerative colitis (group IV). In group I strains, mean basal and peak PGE2 levels after 24 h of interleukin (IL)-1β stimulation were 5.4 ± 1.1 and 32.8 ± 4.9 ng/mg protein, respectively. Mean IL-1β-stimulated peak levels in groups II, III, and IV strains were, respectively, 6-, 9-, and 7-fold greater than that in group I (P < 0.001 for each comparison), and inductions of COX-2 mRNA and protein were consistent with these findings. IL-1β-mediated stimulation of PGE2 was fully blocked in the presence of a nonselective COX inhibitor (indomethacin) or a selective COX-2 inhibitor (NS-398). IL-1β treatment elicited from group I (normal) and group III (cancer-associated) fibroblasts, respectively, ∼2- and 3-fold inductions of COX-2 transcriptional activity and ∼1.4- and 1.7-fold inductions of COX-2 promoter activity. This modestly greater COX-2 transcription rate could not alone account for the dramatically higher levels of COX-2 mRNA and protein and PGE2 in cancer-associated compared with normal fibroblasts. However, incubation of fibroblasts with PGE2 after IL-1β stimulation prolonged COX-2 mRNA half-life from ∼1 to 9 h. Our results strengthen the evidence that fibroblasts and other mesenchymal cells are the source of COX-2 expression in normal and premalignant colorectal tissue. Group II fibroblasts from normal segments of colons that harbored synchronous remote advanced neoplasms behaved like group III fibroblasts from advanced neoplasms and not group I fibroblasts from normal colons. We hypothesize that the effects of modestly greater COX-2 transcription in groups II-IV fibroblasts yield corresponding modest increases in PGE2 synthesis whose effects are progressively amplified through robust stabilization of COX-2 mRNA.

UR - http://www.scopus.com/inward/record.url?scp=0037439928&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037439928&partnerID=8YFLogxK

M3 - Article

C2 - 12543811

AN - SCOPUS:0037439928

VL - 63

SP - 522

EP - 526

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 2

ER -